Research / MNSB / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-26-015780 Bank
Sequential deposit growth 50th Own-history percentile · N=20
Evidence method Sequential · gp.financial.deposits
0.82% · CORE · VALID
Net-income growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.net_income
67.14% · CORE · VALID
Interest-income growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.financial.interest_income
-5.29% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Dec 31, 2021 3/6 normalized Level 3 Mar 31, 2022 5/6 normalized Level 3 Jun 30, 2022 5/5 normalized Level 3 Sep 30, 2022 5/5 normalized Level 3 Dec 31, 2022 4/4 normalized Level 3 Mar 31, 2023 4/4 normalized Level 3 Jun 30, 2023 4/4 normalized Level 3 Sep 30, 2023 4/4 normalized Level 3 Dec 31, 2023 4/4 normalized Level 3 Mar 31, 2024 4/4 normalized Level 3 Jun 30, 2024 3/3 normalized Level 3 Sep 30, 2024 3/3 normalized Level 3 Dec 31, 2024 3/3 normalized Level 3 Mar 31, 2025 3/3 normalized Level 3 Jun 30, 2025 3/3 normalized Level 3 Sep 30, 2025 3/3 normalized Level 3 Dec 31, 2024 4/4 normalized Amended as filed Dec 31, 2025 3/3 normalized Level 3 Mar 31, 2026 3/3 normalized Level 3 Jun 30, 2026 3/3 normalized Level 4 Period transition
What moved in the state? Deposit Growth Decreased
Previous 4.88%
Current 0.82%
Delta -4.06% Interest Income Growth Decreased
Previous -2.25%
Current -5.29%
Delta -3.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.